NCT02968810 2026-03-18
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
24 trialsNCT07469319 2026-03-13
BISHOP
University of Aarhus
Phase NA Recruiting
NCT05095714 2026-03-12
FASTRAK
Assistance Publique - Hôpitaux de Paris
Phase NA Recruiting
NCT03520660 2026-03-11
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
National Institutes of Health Clinical Center (CC)
Phase 4 Active not recruiting
NCT06096779 2026-03-06
Kirros
Genentech, Inc.
Phase 2 Recruiting
NCT04485286 2026-02-27
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
Massachusetts General Hospital
Phase 2 Recruiting
NCT03654053 2026-01-07
SACRED
VA Office of Research and Development
Phase 3 Active not recruiting
NCT00243633 2025-12-23
Characterization of Focal Liver Lesions by Real-time Contrast-enhanced Ultrasound Imaging (CEUS)
University Hospital, Tours
Phase NA Completed
NCT02626312 2025-10-14
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
NCT03612531 2025-10-14
MANTLE
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT06007846 2025-09-30
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Inova Health Care Services
Phase 2/3 Recruiting
NCT05486572 2025-09-26
PREMIUM
VA Office of Research and Development
Phase NA Recruiting
NCT05971108 2025-09-24
REVISE-HCC
Manchester University NHS Foundation Trust
Phase NA Recruiting
NCT07185360 2025-09-22
LIVER-TRACK
Assistance Publique - Hôpitaux de Paris
Phase NA Not yet recruiting
NCT07149506 2025-09-08
OCTOPUS-RD
Universidad de Guanajuato
Phase 3 Enrolling by invitation
NCT07132515 2025-08-20
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Mansoura University
Phase 4 Recruiting
NCT06125743 2025-08-14
Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]
Abramson Cancer Center at Penn Medicine
Phase NA Recruiting
NCT05433467 2025-08-13
CTMH
Northern Jiangsu People's Hospital
Phase NA Recruiting
NCT07042919 2025-06-29
Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer
Northwestern University
Phase 1/2 Not yet recruiting
NCT05339984 2025-06-27
LSM
Assistance Publique - Hôpitaux de Paris
Phase NA Recruiting
NCT03534141 2025-05-16
MHALT
University of California, San Francisco
Phase NA Terminated
NCT05178303 2025-05-16
SB-1121
Trieu, Nguyen Thi, M.D.
Phase 4 Completed
NCT05201404 2025-04-29
LIVERATION
Can-Fite BioPharma
Phase 3 Recruiting
NCT05586516 2025-03-20
A Study to Assess an ATX Inhibitor (IOA-289) in Patients with Metastatic Pancreatic Cancer
iOnctura
Phase 1/2 Active not recruiting